Navigation Links
alo in Medical News

Medical Mystery, 8-Year-Old Hussein Balhas From Lebanon Survives Rare Disease Against All Odds, and Looks for Hope and Solutions From American Doctors

... alo Cultural Foundation coordinates massive effort on ...keting agency Unique Image Inc. and founder of the alo Cultural Foundation (ACF). Kanan learned of Hussei...s and operations have been scheduled. The alo Cultural Foundation is dedicated to building stron...

King Pharmaceuticals To Acquire Alpharma for Approximately $1.6 Billion

...all/ -- King Pharmaceuticals, Inc. (NYSE: KG ) and Alpharma Inc. (NYSE: alo ) today announced that the two companies have signed a definitive merger ag...chnologies to market. About Alpharma Alpharma Inc. (NYSE: alo ) is a global specialty pharmaceutical company with leadership positions in...

National Family Partnership Designates October 27th 'Lock Your Meds' Day

...e, distributes similar materials to members of Congress and supports alternative social activities for youth. About Alpharma Alpharma Inc. (NYSE: alo ) is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: alo ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI ) Ark Therap...

Cipher appoints Stefan Aigner to board of directors

... than 20 years of experience in the global healthcare industry. He is currently the EVP, Corporate and Business Development for Alpharma, Inc. (NYSE: alo ), a leading global specialty pharmaceutical company. Before joining Alpharma, Dr. Aigner was co-founder and Executive Vice President of Business Deve...

More>>

alo in Medical Technology

Research Explores the Effects of Stem Cell Source and Patient Age on Stem Cell Transplantation Outcomes

... Cord Blood [Abstract #151] M ary Eapen, M BBS, the Center for Internation a l Bl o od a nd M arrow Transpla n tation alo n g with the European Group f or Blo od and M arrow Transplan t at i on a nd the N e w York Bloo d Center In th...

Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting

... BRIDGEWATER, N.J., Sept. 9 /PRNewswire-FirstCall/ -- Alpharma Inc. (NYSE: alo ), a global specialty pharmaceutical company, today announced results from ... the year ended December 31, 2007. About Alpharma Alpharma Inc. (NYSE: alo ) is a global specialty pharmaceutical company with leadership positions in...

Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session

... TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- Alpharma Inc. (NYSE: alo ), a global specialty pharmaceutical company, today announced results from ... the year ended December 31, 2007. About Alpharma Alpharma Inc. (NYSE: alo ) is a global specialty pharmaceutical company with leadership positions in...

Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions

... NSAID TAMPA, Fla., May 8 /PRNewswire-FirstCall/ -- Alpharma Inc. (NYSE: alo ), a leading global specialty pharmaceutical company, announced today that ...ebsite: http://www.alpharma.com . About Alpharma Alpharma Inc. (NYSE: alo ) is a global specialty pharmaceutical company with leadership positions in...

More>>

alo in Biological Technology

DURECT's Collaboration With Alpharma Clears HSR Review and Is Effective

...eement with Alpharma Ireland Limited, an affiliate of Alpharma Inc. (NYSE: alo ), granting such party the exclusive worldwide rights to develop and commer...pproval of the product by the FDA. About Alpharma Alpharma Inc. (NYSE: alo ) is a global specialty pharmaceutical company with leadership positions in...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC. (NASDAQ: ALTH ) ALNYLAM PHARMACEUTICALS INC. (NASDAQ: ALNY ) ALPHARMA INC. (NYSE: alo ) ALTUS PHARMACEUTICALS INC. (NASDAQ: ALTU ) AMAG PHARMACEUTICALS INC. (NASDAQ: AMAG ) ANGIOTECH PHARMACEUTICALS INC. (TSE: ANP) APPLIED BIOSYST...

QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)

... ) Add Adolor Corp. (Nasdaq: ADLR ) ALLOS THERAPEUTICS INC. (Nasdaq: ALTH ) Alnylam Pharmaceuticals Inc. (Nasdaq: ALNY ) Alpharma Inc. (NYSE: alo ) Altus Pharmaceuticals Inc. (Nasdaq: ALTU ) AMAG Pharmaceuticals Inc. (Nasdaq: AMAG ) ANGIOTECH PHARMACEUTICALS (Nasdaq: ANPI ) Ark Therapeuti...

QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes

...sdaq: MAXY ) will replace Aspreva Pharmaceutical, Inc. (Nasdaq: ASPV ) in the HealthShares(TM) Autoimmune-Inflammation Index. Alpharma, Inc. (NYSE: alo ) will also replace Aspreva Pharmaceutical, Inc. in the HealthShares(TM) Neuroscience Index. Aspreva Pharmaceutical is being acquired by Galencia Grou...

More>>

Other Tags
(Date:8/27/2014)... participation in the largest ongoing observational study of U.S. ... of the larger patient base, according to a study ... The study authors call into question the general applicability ... the use of broader enrollment criteria and existing patient ... clinical trials can be tremendously expensive and a huge ...
(Date:8/27/2014)... scientists are trying to prevent the onset of ... at Virginia Commonwealth University Massey Cancer Center are ... the process to culminate in cell death rather ... p62 protein, which is often referred to as ... disposing unwanted cellular proteins during autophagy. Results from ...
(Date:8/27/2014)... in Disability (CLD) has received a two-year, $600,000 ... of the Health Resources and Services Administration to ... aimed at improving services for children and youth ... this project, CLD worked with an Autism Advisory ... The resulting plan addresses priorities of increased awareness ...
(Date:8/27/2014)... 8/27/14)Dartmouth cancer researchers developed and tested an advanced ... interactions that contribute to disease as published yesterday ... The approach fills a gap in current analyses. ... interactions among genetic and environmental factors. When many ... versus those that reflect chance combinations among affected ...
(Date:8/27/2014)... CA (PRWEB) August 27, 2014 Jaha was ... do this, Jaha invested in creating the industry’s most affordable ... adding functions that no other apps possess. Jaha ... tracker that differentiates in three simple steps: locate, challenge and ... on Tuesday, Aug 26, 2014 to garner support and to ...
Breaking Medicine News(10 mins):Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Promising new cancer therapy uses molecular 'Trash Man' to exploit a common cancer defense 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Jaha, Inc. The Most Affordable Fitness Band in the Market Released on Kickstarter 2
(Date:8/27/2014)... /PRNewswire-iReach/ -- The IEEE Engineering in Medicine and Biology ... International Conference (EMBC,14), this year being held at the ... Illinois , from Tuesday, August 26 through Saturday, ... industry professionals in science, medicine, and engineering are registered ... This year,s conference theme is ...
(Date:8/27/2014)... as giant, frightening beasts. But every creature is a ... slab containing fossils of 24 very young dinosaurs and ... hatchlings overseen by a caretaker, according to a new ... P. Hedrick and Peter Dodson led the work, collaborating ... where the specimen is held. Hedrick is a doctoral ...
(Date:8/27/2014)... release is available in German . ... is the most common inherited disease affecting the peripheral ... the Max Planck Institute of Experimental Medicine and University ... Schwann cells is impaired in rats with the disease. ... layer known as myelin, which facilitates the rapid transfer ...
Breaking Biology News(10 mins):Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 2Penn paleontologists describe a possible dinosaur nest and young 'babysitter' 3Potential therapy for incurable Charcot-Marie-Tooth disease 2
Other Contents